Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2007, Vol. 12 ›› Issue (1): 103-106.

Previous Articles     Next Articles

Tolerance of ulinastatin in healthy volunteers

WU Cheng-yi1, XIAO Feng1, GAN Lei2, XU Qiang2, YU Xiao-qi2, SHI Li2, ZHENG Qing-shan3, SUN Rui-yuan3, WEI wei1   

  1. 1Clinical Institute of Pharmacologic Research, 2Clinical I Research Institute of the First Affiliated Hospital, Anhui Medical University, Hefei 230032, Anhui, China;
    3Anhui Provincial Center for Drug Clinical Evaluation, Yijishan Hospital, Wannan Medical College, Wuhu 232001, Anhui, China
  • Received:2006-08-07 Revised:2006-10-31 Online:2007-01-26 Published:2020-10-26

Abstract: AIM: To evaluate the tolerance of healthy volunteers to ulinastatin (UTI) in different doses and confirm its safety dose in vivo. METHODS: 44 healthy volunteers were randomized into single rising dose groups (100, 200, 400, 600, 800, 1000, 1200 kU) and multiple rising dose groups (900 or 1200 kU, tid for 7 days). RESULTS: The maximal tolerance single-dose was 1200 kU, and the maximal tolerance multiple-dose was 900kU. CONCLUSION: UTI was safe at a dose from 100 to 1200 kU in a single administration or at a dose from 300 to 900 kU in multiple administration.

Key words: ulinastatin, tolerance, safe dose

CLC Number: